Drug Report History #8417

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v25-FR Version v6-EN
Language French (Updated) English
Date Updated 2018-10-02 (Updated) 2017-07-31
Drug Identification Number 02347830 02347830
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name ROPIVACAINE ROPIVACAINE
Company Name HOSPIRA HEALTHCARE CORPORATION HOSPIRA HEALTHCARE CORPORATION
Ingredients ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION EPIDURAL
Packaging size 10x10mL 10x10mL
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date (Updated) 2017-04-28
Actual start date 2017-05-09 (Updated)
Estimated end date (Updated) 2018-01-31
Actual end date 2018-10-01 (Updated)
Shortage status Resolved (Updated) Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments